Cargando…
A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer
BACKGROUND: This study used bibliometrics to define and analyze the characteristics of the first 100 most cited papers on the topic of neuroendocrine prostate cancer (NEPC). METHODS: We explored the Web of Science Core Collection database, and screened the top 100 most frequently cited articles and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027713/ https://www.ncbi.nlm.nih.gov/pubmed/36959803 http://dx.doi.org/10.3389/fonc.2023.1146515 |
_version_ | 1784909766612484096 |
---|---|
author | Gan, Yu He, Qiangrong Li, Chao Alsharafi, Bassam Lutf Mohammed Zhou, Hengfeng Long, Zhi |
author_facet | Gan, Yu He, Qiangrong Li, Chao Alsharafi, Bassam Lutf Mohammed Zhou, Hengfeng Long, Zhi |
author_sort | Gan, Yu |
collection | PubMed |
description | BACKGROUND: This study used bibliometrics to define and analyze the characteristics of the first 100 most cited papers on the topic of neuroendocrine prostate cancer (NEPC). METHODS: We explored the Web of Science Core Collection database, and screened the top 100 most frequently cited articles and reviews with the title NEPC or small cell prostate cancer (SCPC). We conducted bibliometrics research on the screening results to identify the most influential journals and authors in the field of NEPC. RESULTS: The first 100 most cited papers have been cited a total of 14,795 times, from 73 to 833 times (mean ± standard deviation, 147.95 ± 101.68). All top 100 most cited papers were published from 1984 to 2019, and the total number of citations for papers published in 2016 was significantly higher than that for papers published in other years. The journal with the largest number of published papers is “Prostate” (n=8). “Neuroendocrine differentiation” has become the most frequently used author keyword. “Oncology” is the most popular topic in the field of NEPC. CONCLUSION: We analyzed the first 100 most cited papers in the NEPC field by collecting detailed information, which provide guiding opinions for finding the most influential journals and authors in NEPC-related fields. We hope to help researchers and readers in this field improve their understanding of NEPC research trends and provide ideas for future research from a unique perspective. |
format | Online Article Text |
id | pubmed-10027713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100277132023-03-22 A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer Gan, Yu He, Qiangrong Li, Chao Alsharafi, Bassam Lutf Mohammed Zhou, Hengfeng Long, Zhi Front Oncol Oncology BACKGROUND: This study used bibliometrics to define and analyze the characteristics of the first 100 most cited papers on the topic of neuroendocrine prostate cancer (NEPC). METHODS: We explored the Web of Science Core Collection database, and screened the top 100 most frequently cited articles and reviews with the title NEPC or small cell prostate cancer (SCPC). We conducted bibliometrics research on the screening results to identify the most influential journals and authors in the field of NEPC. RESULTS: The first 100 most cited papers have been cited a total of 14,795 times, from 73 to 833 times (mean ± standard deviation, 147.95 ± 101.68). All top 100 most cited papers were published from 1984 to 2019, and the total number of citations for papers published in 2016 was significantly higher than that for papers published in other years. The journal with the largest number of published papers is “Prostate” (n=8). “Neuroendocrine differentiation” has become the most frequently used author keyword. “Oncology” is the most popular topic in the field of NEPC. CONCLUSION: We analyzed the first 100 most cited papers in the NEPC field by collecting detailed information, which provide guiding opinions for finding the most influential journals and authors in NEPC-related fields. We hope to help researchers and readers in this field improve their understanding of NEPC research trends and provide ideas for future research from a unique perspective. Frontiers Media S.A. 2023-03-07 /pmc/articles/PMC10027713/ /pubmed/36959803 http://dx.doi.org/10.3389/fonc.2023.1146515 Text en Copyright © 2023 Gan, He, Li, Alsharafi, Zhou and Long https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Gan, Yu He, Qiangrong Li, Chao Alsharafi, Bassam Lutf Mohammed Zhou, Hengfeng Long, Zhi A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer |
title | A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer |
title_full | A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer |
title_fullStr | A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer |
title_full_unstemmed | A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer |
title_short | A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer |
title_sort | bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027713/ https://www.ncbi.nlm.nih.gov/pubmed/36959803 http://dx.doi.org/10.3389/fonc.2023.1146515 |
work_keys_str_mv | AT ganyu abibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer AT heqiangrong abibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer AT lichao abibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer AT alsharafibassamlutfmohammed abibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer AT zhouhengfeng abibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer AT longzhi abibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer AT ganyu bibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer AT heqiangrong bibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer AT lichao bibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer AT alsharafibassamlutfmohammed bibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer AT zhouhengfeng bibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer AT longzhi bibliometricstudyofthetop100mostcitedpapersinneuroendocrineprostatecancer |